MedPath

The Sources of Strength Australia Project: a trial investigating the effect of the Sources of Strength program on help-seeking for suicidality in adolescents.

Not Applicable
Completed
Conditions
Help-seekingSuicidality
Help-seeking
Suicidality
Mental Health - Suicide
Registration Number
ACTRN12616000048482
Lead Sponsor
The National Institute for Mental Health Research, The Australian National University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
1781
Inclusion Criteria

Students in Years 7 - 11

Exclusion Criteria

There will be no exclusion criteria applied as this is a universal intervention.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Help-seeking.<br><br>The adapted version of the General Help-Seeking Questionnaire (GHSQ; Wilson et al, 2005) is the primary outcome measure in the current study and assesses intentions to seek help for personal or emotional problems from 11 different formal and informal sources (e.g., friend, parent, psychologist, teacher). Respondents indicate how likely they are to seek help from each of the sources on a scale ranging from 1 (extremely unlikely) to 7 (extremely likely). <br><br>[ Post-intervention questionnaires containing the primary outcome variable will be administered at the conclusion of the 3-month intervention period (at program completion).]
Secondary Outcome Measures
NameTimeMethod
Suicidality.<br><br>Suicidality will be measured by a number of questionnaires. <br><br>The Youth Risk Behaviour Survey (cdc.gov) investigates suicidal ideation, plans and attempts over 4 questions (Yes/No). Suicidal ideation will be further investigated using the Suicidal Ideation Attributes Scale (SIDAS; Van Spijker et al, 2014), which contains 5 questions rated on 10-point scales assessing various levels of severity of suicidal ideation.<br><br><br>[ Post-intervention questionnaires containing secondary outcome variables will be administered at the conclusion of the 3-month intervention period (at program completion).]
© Copyright 2025. All Rights Reserved by MedPath